Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-01-03 @ 11:01 PM
Study NCT ID:
NCT01041859
Status:
COMPLETED
Last Update Posted:
2013-09-11
First Post:
2009-12-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-30
First Submit QC Date:
None
Study First Post Date:
2010-01-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-03-08
Results First Submit QC Date:
None
Results First Post Date:
2012-05-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-08-29
Last Update Post Date:
2013-09-11
Last Update Post Date Type:
ESTIMATED